ArticleJournal of clinical immunology2021

Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation.

Sharat Chandra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.